These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 19267041)

  • 1. The Revised National Tuberculosis Control Programme in India: time for revision of treatment regimens and rapid upscaling of DOTS-plus initiative.
    Bhargava A; Jain Y
    Natl Med J India; 2008; 21(4):187-91. PubMed ID: 19267041
    [No Abstract]   [Full Text] [Related]  

  • 2. Is this the time to revise the Revised National Tuberculosis Control Programme in India?--yes and no..
    Jindal SK; Agarwal R
    Natl Med J India; 2008; 21(4):159-62. PubMed ID: 19267034
    [No Abstract]   [Full Text] [Related]  

  • 3. Beyond DOtS: avenues ahead in the management of tuberculosis.
    Chaudhury RR; Thatte U
    Natl Med J India; 2003; 16(6):321-7. PubMed ID: 14765625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment outcome cohort analysis in an integrated DOTS and DOTS-Plus TB program in Latvia.
    Riekstina V; Leimane V; Holtz TH; Leimans J; Wells CD
    Int J Tuberc Lung Dis; 2007 May; 11(5):585-7. PubMed ID: 17439686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revised National Tuberculosis Control Programme: Indian perspective.
    Arora VK; Sarin R
    Indian J Chest Dis Allied Sci; 2000; 42(1):21-6. PubMed ID: 10851818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of pediatric tuberculosis under the Revised National Tuberculosis Control Program (RNTCP).
    Chauhan LS; Arora VK; ;
    Indian Pediatr; 2004 Sep; 41(9):901-5. PubMed ID: 15475631
    [No Abstract]   [Full Text] [Related]  

  • 7. Results of a standardised regimen for multidrug-resistant tuberculosis in Bangladesh.
    Van Deun A; Salim MA; Das AP; Bastian I; Portaels F
    Int J Tuberc Lung Dis; 2004 May; 8(5):560-7. PubMed ID: 15137531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A poor drug-resistant tuberculosis programme is worse than no programme: time for a change.
    Chiang CY; Van Deun A; Enarson DA
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):714-8. PubMed ID: 23575274
    [No Abstract]   [Full Text] [Related]  

  • 9. Intensified scale-up of public-private mix: a systems approach to tuberculosis care and control in India.
    Lal SS; Sahu S; Wares F; Lönnroth K; Chauhan LS; Uplekar M
    Int J Tuberc Lung Dis; 2011 Jan; 15(1):97-104. PubMed ID: 21276304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance with DOTS diagnosis and treatment recommendations by private practitioners in Kerala, India.
    Greaves F; Ouyang H; Pefole M; MacCarthy S; Cash RA
    Int J Tuberc Lung Dis; 2007 Jan; 11(1):110-2. PubMed ID: 17217139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis in childhood.
    Shingadia D
    Ther Adv Respir Dis; 2012 Jun; 6(3):161-71. PubMed ID: 22361927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment outcome of neuro tuberculosis patients put on DOTS--an observation study from the field.
    Venugopal K; Sreelatha PR; Philip S; Kumar V
    Indian J Tuberc; 2008 Oct; 55(4):199-202. PubMed ID: 19295107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Weight gain in patients with tuberculosis treated under directly observed treatment short-course (DOTS).
    Vasantha M; Gopi PG; Subramani R
    Indian J Tuberc; 2009 Jan; 56(1):5-9. PubMed ID: 19402266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An expanded DOTS framework for effective tuberculosis control.
    Int J Tuberc Lung Dis; 2002 May; 6(5):378-88. PubMed ID: 12019913
    [No Abstract]   [Full Text] [Related]  

  • 15. DOTS at a tertiary care center in northern India: successes, challenges and the next steps in tuberculosis control.
    ; ; . PubMed ID: 16873915
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 33.